Pharmaceutical-Biotech Industry to Wrap Up Year With $4.5 Billion Investment in Fourth-Quarter 2014 Project Starts, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Oct 30, 2014) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- By the end of 2014, the Pharmaceutical-Biotech Industry is forecast to have begun $4.5 billion in capital and maintenance (MRO) projects. A recent survey of Industrial Info's project database returned 251 active North American projects with a total investment value (TIV) of $4.5 billion that are scheduled to begin construction during the fourth quarter of 2014. The projects are scattered throughout the North America and represent an average project TIV of $18 million.

Within this article: Details on the growing industry, including key projects from major companies such as Baxter International (NYSE:BAX), General Electric (NYSE:GE) and Bocchi Laboratories.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.

Contact:
William Ploch
713-783-5147